# A Study of the Pharmacokinetics and Immunologic Effects of Lipoic Acid in Multiple Sclerosis

> **NCT00676156** · PHASE1 · COMPLETED · sponsor: **Oregon Health and Science University** · enrollment: 40 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** oral lipoic acid (LA)
- **DRUG:** lipoic acid (LA) with fish oil and LA without fish oil
- **DRUG:** R lipoic acid

## Key facts

- **NCT ID:** NCT00676156
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2008-02
- **Final completion:** 2008-11
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2012-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00676156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00676156, "A Study of the Pharmacokinetics and Immunologic Effects of Lipoic Acid in Multiple Sclerosis". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00676156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*